Increasing data suggests that an intact immune system is required for improvedoutcomes in patients with Human Epidermal Growth Factor Receptor 2 (HER2+) and Triple Negative Breast Cancer (TNBC) [...].
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367276 | PMC |
http://dx.doi.org/10.3390/cancers14153762 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!